No abstract available
MeSH terms
-
Adult
-
Age Factors
-
Anticarcinogenic Agents / therapeutic use*
-
Breast Neoplasms / drug therapy*
-
Breast Neoplasms / metabolism
-
Breast Neoplasms / surgery
-
Combined Modality Therapy
-
Disease-Free Survival
-
Female
-
Humans
-
Middle Aged
-
Ovary / surgery
-
Premenopause
-
Prognosis
-
Receptors, Estrogen / metabolism*
-
Tamoxifen / therapeutic use*
Substances
-
Anticarcinogenic Agents
-
Receptors, Estrogen
-
Tamoxifen